| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sirtuins | 27 | 2022 | 74 | 10.760 |
Why?
|
| Lysine | 27 | 2025 | 181 | 9.290 |
Why?
|
| Sirtuin 2 | 20 | 2025 | 30 | 9.130 |
Why?
|
| Histidine | 18 | 2021 | 76 | 7.460 |
Why?
|
| Protein Processing, Post-Translational | 21 | 2024 | 402 | 5.270 |
Why?
|
| Histone Deacetylase Inhibitors | 13 | 2023 | 106 | 5.130 |
Why?
|
| Iron-Sulfur Proteins | 9 | 2021 | 21 | 4.600 |
Why?
|
| Acyltransferases | 10 | 2025 | 52 | 4.600 |
Why?
|
| Lipoylation | 7 | 2025 | 36 | 4.090 |
Why?
|
| Histone Deacetylases | 13 | 2023 | 86 | 4.030 |
Why?
|
| NAD | 16 | 2021 | 92 | 3.920 |
Why?
|
| S-Adenosylmethionine | 10 | 2021 | 27 | 3.610 |
Why?
|
| Saccharomyces cerevisiae Proteins | 8 | 2021 | 297 | 3.390 |
Why?
|
| Pyrococcus horikoshii | 10 | 2019 | 10 | 3.230 |
Why?
|
| Cysteine | 8 | 2024 | 143 | 3.110 |
Why?
|
| Archaeal Proteins | 8 | 2019 | 26 | 3.020 |
Why?
|
| Proteins | 9 | 2023 | 802 | 2.710 |
Why?
|
| Saccharomyces cerevisiae | 12 | 2022 | 456 | 2.680 |
Why?
|
| Acylation | 20 | 2024 | 61 | 2.570 |
Why?
|
| Fatty Acids | 7 | 2024 | 149 | 2.560 |
Why?
|
| Proteomics | 9 | 2023 | 246 | 2.550 |
Why?
|
| Antineoplastic Agents | 13 | 2024 | 2366 | 2.340 |
Why?
|
| Enzyme Assays | 4 | 2021 | 19 | 2.240 |
Why?
|
| Fluorescent Dyes | 6 | 2020 | 260 | 2.170 |
Why?
|
| Sirtuin 3 | 5 | 2024 | 36 | 2.100 |
Why?
|
| HEK293 Cells | 15 | 2025 | 667 | 2.080 |
Why?
|
| Histones | 11 | 2022 | 350 | 2.070 |
Why?
|
| Peptides | 10 | 2023 | 655 | 1.920 |
Why?
|
| Immunity, Innate | 3 | 2024 | 441 | 1.770 |
Why?
|
| Peptide Elongation Factor 2 | 7 | 2021 | 13 | 1.750 |
Why?
|
| Repressor Proteins | 4 | 2021 | 436 | 1.710 |
Why?
|
| ADP-ribosyl Cyclase 1 | 8 | 2021 | 19 | 1.650 |
Why?
|
| Enzyme Inhibitors | 7 | 2021 | 651 | 1.620 |
Why?
|
| Biosynthetic Pathways | 5 | 2018 | 15 | 1.600 |
Why?
|
| Th17 Cells | 2 | 2025 | 95 | 1.520 |
Why?
|
| Poly(ADP-ribose) Polymerases | 3 | 2020 | 53 | 1.510 |
Why?
|
| Adenosine Diphosphate Ribose | 5 | 2024 | 13 | 1.440 |
Why?
|
| Mice | 31 | 2025 | 12133 | 1.410 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 3 | 2024 | 8 | 1.390 |
Why?
|
| Acyl Coenzyme A | 3 | 2022 | 20 | 1.380 |
Why?
|
| Animals | 46 | 2025 | 28059 | 1.370 |
Why?
|
| Humans | 86 | 2025 | 92352 | 1.360 |
Why?
|
| Stress, Physiological | 2 | 2025 | 245 | 1.330 |
Why?
|
| Neoplasms | 7 | 2023 | 3123 | 1.320 |
Why?
|
| Colitis | 2 | 2024 | 253 | 1.250 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2022 | 170 | 1.250 |
Why?
|
| Aldehyde Dehydrogenase | 2 | 2019 | 17 | 1.250 |
Why?
|
| Antiviral Agents | 2 | 2024 | 498 | 1.230 |
Why?
|
| Acetylation | 10 | 2025 | 146 | 1.190 |
Why?
|
| Acetyltransferases | 3 | 2024 | 36 | 1.160 |
Why?
|
| Cell Differentiation | 4 | 2025 | 1607 | 1.150 |
Why?
|
| Alkyl and Aryl Transferases | 2 | 2018 | 17 | 1.140 |
Why?
|
| Fluorescence Polarization | 2 | 2024 | 11 | 1.080 |
Why?
|
| Biological Assay | 2 | 2019 | 81 | 1.080 |
Why?
|
| Mitochondria | 5 | 2024 | 595 | 1.070 |
Why?
|
| Sirtuin 1 | 4 | 2022 | 36 | 1.060 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 3 | 2024 | 187 | 1.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2024 | 25 | 1.050 |
Why?
|
| Inflammasomes | 2 | 2024 | 29 | 1.040 |
Why?
|
| Drug Discovery | 2 | 2025 | 110 | 1.000 |
Why?
|
| Cell Line, Tumor | 13 | 2024 | 2662 | 0.970 |
Why?
|
| Molecular Structure | 12 | 2021 | 308 | 0.970 |
Why?
|
| High-Throughput Screening Assays | 3 | 2021 | 60 | 0.970 |
Why?
|
| Vesicular Transport Proteins | 3 | 2019 | 66 | 0.950 |
Why?
|
| Acetate-CoA Ligase | 1 | 2025 | 3 | 0.950 |
Why?
|
| STAT3 Transcription Factor | 3 | 2025 | 87 | 0.940 |
Why?
|
| Smad2 Protein | 1 | 2025 | 23 | 0.940 |
Why?
|
| Lipogenesis | 1 | 2025 | 25 | 0.940 |
Why?
|
| Shigella flexneri | 1 | 2025 | 1 | 0.940 |
Why?
|
| 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | 1 | 2025 | 2 | 0.940 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2025 | 60 | 0.920 |
Why?
|
| Drug Design | 3 | 2019 | 130 | 0.900 |
Why?
|
| RNA, Transfer | 2 | 2016 | 167 | 0.900 |
Why?
|
| Cell Movement | 2 | 2019 | 801 | 0.890 |
Why?
|
| Mitochondrial Membranes | 1 | 2024 | 18 | 0.890 |
Why?
|
| Signal Transduction | 10 | 2025 | 3505 | 0.870 |
Why?
|
| Palmitic Acid | 2 | 2021 | 29 | 0.830 |
Why?
|
| Substrate Specificity | 10 | 2020 | 362 | 0.820 |
Why?
|
| Cell Proliferation | 10 | 2024 | 1720 | 0.810 |
Why?
|
| Structure-Activity Relationship | 10 | 2024 | 432 | 0.800 |
Why?
|
| Lysine Acetyltransferases | 1 | 2022 | 1 | 0.790 |
Why?
|
| Multiple Sclerosis | 1 | 2025 | 260 | 0.790 |
Why?
|
| Shigella | 1 | 2022 | 2 | 0.780 |
Why?
|
| Dysentery, Bacillary | 1 | 2022 | 3 | 0.780 |
Why?
|
| Proteome | 4 | 2022 | 149 | 0.780 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 540 | 0.780 |
Why?
|
| Amino Acid Sequence | 9 | 2022 | 2075 | 0.780 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 316 | 0.770 |
Why?
|
| Kinetics | 9 | 2020 | 1552 | 0.770 |
Why?
|
| ADP-Ribosylation Factors | 2 | 2020 | 11 | 0.770 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 2022 | 7 | 0.760 |
Why?
|
| Peptide Initiation Factors | 1 | 2022 | 30 | 0.760 |
Why?
|
| Transcription Factors | 2 | 2021 | 1688 | 0.750 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2023 | 408 | 0.750 |
Why?
|
| Crystallography, X-Ray | 11 | 2020 | 508 | 0.750 |
Why?
|
| Mentors | 1 | 2023 | 95 | 0.740 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2020 | 139 | 0.740 |
Why?
|
| Mice, Knockout | 10 | 2024 | 2098 | 0.710 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 705 | 0.700 |
Why?
|
| Cell Nucleus | 2 | 2020 | 612 | 0.700 |
Why?
|
| Virus Diseases | 1 | 2021 | 99 | 0.700 |
Why?
|
| Gene Expression Regulation | 4 | 2022 | 2010 | 0.690 |
Why?
|
| Terpenes | 1 | 2020 | 18 | 0.690 |
Why?
|
| Proteolysis | 4 | 2022 | 122 | 0.680 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2018 | 309 | 0.670 |
Why?
|
| Lysosomes | 3 | 2022 | 117 | 0.660 |
Why?
|
| Lipopeptides | 2 | 2019 | 19 | 0.660 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 764 | 0.650 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2019 | 2 | 0.640 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 181 | 0.630 |
Why?
|
| Glucosides | 1 | 2019 | 14 | 0.630 |
Why?
|
| Communicable Diseases | 1 | 2020 | 65 | 0.620 |
Why?
|
| Thiourea | 1 | 2019 | 10 | 0.620 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 808 | 0.620 |
Why?
|
| Hydroxymethyl and Formyl Transferases | 1 | 2019 | 2 | 0.620 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2019 | 5 | 0.620 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 815 | 0.620 |
Why?
|
| Calcium | 1 | 2023 | 1184 | 0.610 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 167 | 0.610 |
Why?
|
| FMN Reductase | 2 | 2015 | 2 | 0.610 |
Why?
|
| Desulfotomaculum | 2 | 2015 | 3 | 0.610 |
Why?
|
| Organometallic Compounds | 2 | 2018 | 141 | 0.610 |
Why?
|
| Mammals | 1 | 2021 | 247 | 0.600 |
Why?
|
| Inflammation | 2 | 2022 | 1024 | 0.590 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 69 | 0.590 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 2450 | 0.580 |
Why?
|
| Staining and Labeling | 1 | 2019 | 168 | 0.580 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 293 | 0.580 |
Why?
|
| Chromatin | 3 | 2022 | 426 | 0.570 |
Why?
|
| Mutation | 8 | 2022 | 4213 | 0.570 |
Why?
|
| Drug Screening Assays, Antitumor | 5 | 2021 | 83 | 0.560 |
Why?
|
| Succinic Acid | 2 | 2022 | 10 | 0.560 |
Why?
|
| Interferon Type I | 1 | 2019 | 195 | 0.560 |
Why?
|
| Iron | 4 | 2021 | 175 | 0.560 |
Why?
|
| Protein Binding | 7 | 2024 | 1513 | 0.550 |
Why?
|
| Sirolimus | 1 | 2018 | 175 | 0.540 |
Why?
|
| Junctional Adhesion Molecule C | 1 | 2017 | 1 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 3376 | 0.540 |
Why?
|
| Oxygen | 1 | 2022 | 762 | 0.530 |
Why?
|
| Click Chemistry | 1 | 2017 | 5 | 0.530 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2016 | 1 | 0.520 |
Why?
|
| Cytokines | 1 | 2021 | 842 | 0.520 |
Why?
|
| RNA, Ribosomal | 1 | 2016 | 70 | 0.520 |
Why?
|
| Hydrolysis | 6 | 2016 | 144 | 0.520 |
Why?
|
| Uridine | 1 | 2016 | 58 | 0.510 |
Why?
|
| Ubiquitination | 3 | 2025 | 79 | 0.510 |
Why?
|
| Enzymes | 1 | 2016 | 46 | 0.500 |
Why?
|
| ras Proteins | 1 | 2017 | 133 | 0.500 |
Why?
|
| Mutant Proteins | 1 | 2016 | 97 | 0.490 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 109 | 0.490 |
Why?
|
| Tight Junctions | 1 | 2017 | 151 | 0.490 |
Why?
|
| Oncogene Proteins | 1 | 2016 | 64 | 0.480 |
Why?
|
| Cardiomegaly | 1 | 2016 | 121 | 0.480 |
Why?
|
| Free Radicals | 2 | 2017 | 70 | 0.470 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 291 | 0.460 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2014 | 5 | 0.460 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 438 | 0.450 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 597 | 0.440 |
Why?
|
| Protein Domains | 3 | 2024 | 143 | 0.420 |
Why?
|
| Cell Membrane Permeability | 1 | 2014 | 119 | 0.420 |
Why?
|
| ADP Ribose Transferases | 2 | 2013 | 6 | 0.420 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 85 | 0.410 |
Why?
|
| Models, Molecular | 8 | 2020 | 1337 | 0.410 |
Why?
|
| Chromatography, Thin Layer | 1 | 2013 | 34 | 0.400 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 2012 | 6 | 0.400 |
Why?
|
| Myocardium | 1 | 2016 | 586 | 0.400 |
Why?
|
| Cell Membrane | 4 | 2020 | 684 | 0.390 |
Why?
|
| Ligases | 1 | 2012 | 47 | 0.390 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2024 | 501 | 0.390 |
Why?
|
| Methyltransferases | 2 | 2011 | 198 | 0.390 |
Why?
|
| Phosphates | 1 | 2013 | 163 | 0.380 |
Why?
|
| Succinates | 1 | 2012 | 23 | 0.380 |
Why?
|
| Myristic Acid | 2 | 2023 | 4 | 0.370 |
Why?
|
| Histone Acetyltransferases | 2 | 2022 | 44 | 0.370 |
Why?
|
| Recombinant Proteins | 5 | 2020 | 1016 | 0.370 |
Why?
|
| Sulfhydryl Compounds | 1 | 2012 | 69 | 0.360 |
Why?
|
| Plasmodium falciparum | 1 | 2011 | 48 | 0.360 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2011 | 63 | 0.360 |
Why?
|
| Glycine | 2 | 2023 | 95 | 0.360 |
Why?
|
| Binding Sites | 5 | 2019 | 1131 | 0.360 |
Why?
|
| Protozoan Proteins | 1 | 2011 | 74 | 0.350 |
Why?
|
| Protein Multimerization | 4 | 2019 | 184 | 0.350 |
Why?
|
| Oxidation-Reduction | 4 | 2019 | 402 | 0.350 |
Why?
|
| Mutation, Missense | 1 | 2012 | 288 | 0.350 |
Why?
|
| HeLa Cells | 4 | 2021 | 514 | 0.340 |
Why?
|
| Peptide Fragments | 1 | 2013 | 465 | 0.340 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2021 | 1938 | 0.330 |
Why?
|
| Nicotinamide Mononucleotide | 2 | 2009 | 2 | 0.330 |
Why?
|
| Protein Isoforms | 2 | 2022 | 284 | 0.320 |
Why?
|
| Cell Line | 3 | 2020 | 2504 | 0.320 |
Why?
|
| Methylation | 3 | 2018 | 280 | 0.320 |
Why?
|
| MCF-7 Cells | 3 | 2019 | 117 | 0.310 |
Why?
|
| Oxidative Stress | 3 | 2021 | 464 | 0.310 |
Why?
|
| Phosphorylation | 2 | 2025 | 1138 | 0.310 |
Why?
|
| Catalysis | 3 | 2019 | 210 | 0.300 |
Why?
|
| A549 Cells | 2 | 2019 | 48 | 0.290 |
Why?
|
| Virulence Factors | 2 | 2022 | 113 | 0.280 |
Why?
|
| Protein Aggregates | 2 | 2024 | 27 | 0.270 |
Why?
|
| Protein Transport | 2 | 2020 | 430 | 0.260 |
Why?
|
| Genomics | 1 | 2012 | 805 | 0.260 |
Why?
|
| Carbon | 2 | 2018 | 96 | 0.260 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2024 | 609 | 0.240 |
Why?
|
| Breast Neoplasms | 4 | 2022 | 3054 | 0.240 |
Why?
|
| Amino Acids | 2 | 2024 | 256 | 0.240 |
Why?
|
| Phenotype | 3 | 2025 | 2503 | 0.240 |
Why?
|
| Molecular Docking Simulation | 3 | 2021 | 54 | 0.240 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 2 | 2022 | 21 | 0.240 |
Why?
|
| Biocatalysis | 3 | 2017 | 52 | 0.240 |
Why?
|
| Niacinamide | 2 | 2016 | 101 | 0.230 |
Why?
|
| Catalytic Domain | 3 | 2019 | 159 | 0.220 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2025 | 150 | 0.220 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 1 | 2024 | 3 | 0.220 |
Why?
|
| Chikungunya virus | 1 | 2024 | 4 | 0.220 |
Why?
|
| Furans | 1 | 2024 | 18 | 0.220 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 3023 | 0.220 |
Why?
|
| Adenosine Monophosphate | 1 | 2024 | 29 | 0.220 |
Why?
|
| trans-Golgi Network | 1 | 2024 | 13 | 0.220 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2024 | 12 | 0.220 |
Why?
|
| Tretinoin | 2 | 2017 | 131 | 0.220 |
Why?
|
| Virulence | 1 | 2025 | 277 | 0.220 |
Why?
|
| Hydroxylamine | 2 | 2024 | 7 | 0.210 |
Why?
|
| Energy Metabolism | 2 | 2019 | 302 | 0.210 |
Why?
|
| Quinolines | 1 | 2024 | 87 | 0.210 |
Why?
|
| Neuralgia | 1 | 2023 | 33 | 0.210 |
Why?
|
| RNA-Binding Proteins | 2 | 2022 | 284 | 0.200 |
Why?
|
| Adenosine Diphosphate | 1 | 2023 | 58 | 0.200 |
Why?
|
| Cadherins | 1 | 2024 | 165 | 0.200 |
Why?
|
| Indicators and Reagents | 1 | 2023 | 70 | 0.200 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 103 | 0.200 |
Why?
|
| HL-60 Cells | 3 | 2017 | 25 | 0.200 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 319 | 0.200 |
Why?
|
| Hydroxylation | 1 | 2022 | 18 | 0.190 |
Why?
|
| Homeostasis | 3 | 2023 | 452 | 0.190 |
Why?
|
| Astrocytes | 1 | 2022 | 143 | 0.190 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2013 | 95 | 0.190 |
Why?
|
| Endoplasmic Reticulum | 1 | 2023 | 259 | 0.190 |
Why?
|
| Armadillo Domain Proteins | 1 | 2021 | 4 | 0.190 |
Why?
|
| Nucleotides | 1 | 2022 | 98 | 0.190 |
Why?
|
| Histone Deacetylase 6 | 1 | 2021 | 3 | 0.190 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 26 | 0.190 |
Why?
|
| Escherichia coli | 3 | 2015 | 614 | 0.180 |
Why?
|
| Palmitates | 1 | 2021 | 16 | 0.180 |
Why?
|
| Gene Deletion | 2 | 2014 | 354 | 0.180 |
Why?
|
| Diphtheria Toxin | 2 | 2013 | 22 | 0.180 |
Why?
|
| Golgi Apparatus | 1 | 2022 | 117 | 0.180 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 38 | 0.180 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 61 | 0.180 |
Why?
|
| Dithionite | 1 | 2021 | 3 | 0.180 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2021 | 44 | 0.180 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 237 | 0.180 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2016 | 324 | 0.180 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2021 | 37 | 0.180 |
Why?
|
| Chromatography, Liquid | 2 | 2012 | 101 | 0.180 |
Why?
|
| Carbamates | 1 | 2021 | 16 | 0.180 |
Why?
|
| tau Proteins | 1 | 2022 | 78 | 0.180 |
Why?
|
| Phosphorus Radioisotopes | 2 | 2012 | 21 | 0.180 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2022 | 145 | 0.180 |
Why?
|
| Lipids | 1 | 2022 | 278 | 0.180 |
Why?
|
| Male | 7 | 2023 | 43929 | 0.180 |
Why?
|
| Endocytosis | 1 | 2022 | 185 | 0.180 |
Why?
|
| Mass Spectrometry | 2 | 2012 | 198 | 0.170 |
Why?
|
| Garcinia | 1 | 2020 | 1 | 0.170 |
Why?
|
| Zinc | 1 | 2021 | 100 | 0.170 |
Why?
|
| HCT116 Cells | 2 | 2018 | 159 | 0.170 |
Why?
|
| Anthracenes | 1 | 2020 | 16 | 0.170 |
Why?
|
| Thiolester Hydrolases | 1 | 2020 | 15 | 0.170 |
Why?
|
| Adipocytes | 1 | 2022 | 170 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 227 | 0.170 |
Why?
|
| Macrophages | 1 | 2024 | 601 | 0.170 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2020 | 3 | 0.170 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2021 | 57 | 0.170 |
Why?
|
| ADP-Ribosylation | 1 | 2020 | 3 | 0.170 |
Why?
|
| Cytidine Triphosphate | 1 | 2020 | 3 | 0.170 |
Why?
|
| Uridine Triphosphate | 1 | 2020 | 7 | 0.160 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2020 | 10 | 0.160 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2017 | 14 | 0.160 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 383 | 0.160 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 88 | 0.160 |
Why?
|
| NADP | 1 | 2019 | 51 | 0.160 |
Why?
|
| Feedback, Physiological | 1 | 2020 | 69 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 250 | 0.160 |
Why?
|
| Oxidoreductases | 1 | 2019 | 113 | 0.160 |
Why?
|
| Cell Survival | 2 | 2019 | 1006 | 0.160 |
Why?
|
| Antioxidants | 1 | 2020 | 224 | 0.150 |
Why?
|
| Female | 8 | 2022 | 47901 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 1593 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 178 | 0.150 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2018 | 5 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 151 | 0.150 |
Why?
|
| Gluconeogenesis | 1 | 2018 | 15 | 0.150 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2018 | 42 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2025 | 907 | 0.150 |
Why?
|
| Solubility | 1 | 2019 | 185 | 0.150 |
Why?
|
| Genomic Instability | 1 | 2019 | 85 | 0.150 |
Why?
|
| Metabolomics | 2 | 2016 | 95 | 0.150 |
Why?
|
| Myristic Acids | 1 | 2018 | 4 | 0.140 |
Why?
|
| Protein Prenylation | 1 | 2018 | 10 | 0.140 |
Why?
|
| Palmitic Acids | 1 | 2018 | 9 | 0.140 |
Why?
|
| Iron Overload | 1 | 2017 | 6 | 0.140 |
Why?
|
| Histone Deacetylase 1 | 1 | 2017 | 16 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2020 | 726 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 351 | 0.140 |
Why?
|
| Isoenzymes | 1 | 2018 | 276 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 1247 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2022 | 1072 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 1308 | 0.140 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 53 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 462 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 518 | 0.140 |
Why?
|
| Benzamides | 2 | 2017 | 239 | 0.130 |
Why?
|
| RNA, Ribosomal, 5S | 1 | 2016 | 1 | 0.130 |
Why?
|
| RNA, Ribosomal, 5.8S | 1 | 2016 | 2 | 0.130 |
Why?
|
| Jurkat Cells | 1 | 2017 | 82 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 816 | 0.130 |
Why?
|
| Diet, High-Fat | 2 | 2015 | 128 | 0.130 |
Why?
|
| Fibroblasts | 2 | 2017 | 771 | 0.130 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2017 | 69 | 0.130 |
Why?
|
| DNA Repair | 1 | 2019 | 368 | 0.130 |
Why?
|
| Alkenes | 1 | 2016 | 15 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1172 | 0.130 |
Why?
|
| Anisotropy | 1 | 2016 | 63 | 0.130 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2016 | 6 | 0.130 |
Why?
|
| Electrons | 1 | 2016 | 50 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1241 | 0.120 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 111 | 0.120 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 503 | 0.120 |
Why?
|
| Butyrates | 1 | 2016 | 53 | 0.120 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 65 | 0.120 |
Why?
|
| Fluorescence | 1 | 2016 | 104 | 0.120 |
Why?
|
| Organelles | 1 | 2016 | 57 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2016 | 695 | 0.120 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2017 | 79 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 389 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 742 | 0.110 |
Why?
|
| Ferric Compounds | 1 | 2015 | 40 | 0.110 |
Why?
|
| Naphthols | 1 | 2014 | 5 | 0.110 |
Why?
|
| Metals | 1 | 2015 | 100 | 0.110 |
Why?
|
| Electron Transport | 1 | 2014 | 75 | 0.110 |
Why?
|
| Exotoxins | 1 | 2013 | 21 | 0.110 |
Why?
|
| RNA | 2 | 2022 | 589 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 282 | 0.100 |
Why?
|
| Glutamate Dehydrogenase | 1 | 2013 | 8 | 0.100 |
Why?
|
| Rosaniline Dyes | 1 | 2012 | 9 | 0.100 |
Why?
|
| Metabolome | 1 | 2013 | 61 | 0.100 |
Why?
|
| Autoradiography | 1 | 2012 | 69 | 0.100 |
Why?
|
| Bacterial Toxins | 1 | 2013 | 115 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 269 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 105 | 0.090 |
Why?
|
| Plasmids | 1 | 2012 | 288 | 0.090 |
Why?
|
| Transfection | 1 | 2014 | 901 | 0.090 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2011 | 5 | 0.090 |
Why?
|
| Mitochondria, Liver | 1 | 2011 | 29 | 0.090 |
Why?
|
| DNA Primers | 1 | 2012 | 543 | 0.090 |
Why?
|
| Antigenic Variation | 1 | 2011 | 28 | 0.090 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 643 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 335 | 0.090 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 2011 | 5 | 0.090 |
Why?
|
| Alkylation | 1 | 2011 | 32 | 0.090 |
Why?
|
| Cyclopropanes | 1 | 2011 | 26 | 0.090 |
Why?
|
| Hydrogen Bonding | 1 | 2011 | 149 | 0.090 |
Why?
|
| Immune Evasion | 1 | 2011 | 35 | 0.090 |
Why?
|
| Nucleosides | 1 | 2011 | 23 | 0.090 |
Why?
|
| Cattle | 1 | 2011 | 381 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 694 | 0.090 |
Why?
|
| Tankyrases | 1 | 2010 | 1 | 0.090 |
Why?
|
| Citric Acid Cycle | 2 | 2021 | 27 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 1043 | 0.080 |
Why?
|
| Biotinylation | 1 | 2010 | 41 | 0.080 |
Why?
|
| Cytosine | 1 | 2011 | 131 | 0.080 |
Why?
|
| Glutamine | 2 | 2021 | 95 | 0.080 |
Why?
|
| Indoles | 2 | 2021 | 305 | 0.080 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2009 | 7 | 0.080 |
Why?
|
| Alkynes | 1 | 2009 | 19 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 876 | 0.080 |
Why?
|
| Rhodamines | 1 | 2009 | 20 | 0.080 |
Why?
|
| Protein Conformation | 3 | 2019 | 902 | 0.080 |
Why?
|
| Adenosine | 1 | 2011 | 250 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2007 | 107 | 0.070 |
Why?
|
| DNA | 1 | 2011 | 1314 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2021 | 515 | 0.060 |
Why?
|
| Apoptosis | 2 | 2021 | 1737 | 0.060 |
Why?
|
| Hydroxylamines | 1 | 2024 | 8 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 867 | 0.050 |
Why?
|
| Neoplastic Processes | 1 | 2022 | 2 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2017 | 740 | 0.050 |
Why?
|
| Brain | 2 | 2023 | 2353 | 0.050 |
Why?
|
| 3T3-L1 Cells | 1 | 2022 | 35 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2023 | 213 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1785 | 0.050 |
Why?
|
| K562 Cells | 1 | 2021 | 47 | 0.050 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2021 | 18 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2023 | 167 | 0.050 |
Why?
|
| Nucleosomes | 1 | 2022 | 58 | 0.050 |
Why?
|
| Autopsy | 1 | 2022 | 123 | 0.050 |
Why?
|
| Thalidomide | 1 | 2021 | 56 | 0.050 |
Why?
|
| Cholesterol | 1 | 2023 | 362 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 128 | 0.040 |
Why?
|
| Heterografts | 1 | 2021 | 107 | 0.040 |
Why?
|
| Methanobrevibacter | 1 | 2019 | 3 | 0.040 |
Why?
|
| Thionucleosides | 1 | 2019 | 9 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2021 | 270 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1045 | 0.040 |
Why?
|
| Deoxyadenosines | 1 | 2019 | 24 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 825 | 0.040 |
Why?
|
| Acetyl Coenzyme A | 1 | 2019 | 13 | 0.040 |
Why?
|
| Multivesicular Bodies | 1 | 2019 | 1 | 0.040 |
Why?
|
| Arginine | 1 | 2019 | 140 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 457 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 280 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1105 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 206 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 265 | 0.040 |
Why?
|
| Exosomes | 1 | 2019 | 57 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 221 | 0.040 |
Why?
|
| CD11b Antigen | 1 | 2017 | 37 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2017 | 75 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 1900 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 569 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 86 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 1480 | 0.030 |
Why?
|
| Pyridines | 1 | 2017 | 312 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 272 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 281 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2012 | 101 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2017 | 2037 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2903 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2013 | 335 | 0.020 |
Why?
|
| Inosine Nucleotides | 1 | 2009 | 1 | 0.020 |
Why?
|
| Aplysia | 1 | 2009 | 6 | 0.020 |
Why?
|
| Glycosides | 1 | 2008 | 21 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2793 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 1847 | 0.010 |
Why?
|